These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32116488)

  • 21. Kinematic Metrics from a Wireless Stylus Quantify Tremor and Bradykinesia in Parkinson's Disease.
    Maldonado-Naranjo A; Koop MM; Hogue O; Alberts J; Machado A
    Parkinsons Dis; 2019; 2019():6850478. PubMed ID: 31061696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.
    Liang GS; Chou KL; Baltuch GH; Jaggi JL; Loveland-Jones C; Leng L; Maccarone H; Hurtig HI; Colcher A; Stern MB; Kleiner-Fisman G; Simuni T; Siderowf AD
    Stereotact Funct Neurosurg; 2006; 84(5-6):221-7. PubMed ID: 17063043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease].
    Chen J; Liu JL; Chen X; Qian H; Xian WB; Zhou HY; Liu YM; Ye XF; Zheng YF; Zhang SL; Chen L; Li JR; Liu ZL; Pei Z
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):291-5. PubMed ID: 21419000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep brain nucleus targeting in Parkinson's disease and essential tremor by image guided surgery using neuronavigation system with tractography and volume of tissue of activated assessment.
    Seddighi AS; Seddighi A; Nikouei A
    Hell J Nucl Med; 2017; 20 Suppl():14-19. PubMed ID: 29324910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.
    Vizcarra JA; Situ-Kcomt M; Artusi CA; Duker AP; Lopiano L; Okun MS; Espay AJ; Merola A
    J Neurol; 2019 Feb; 266(2):289-297. PubMed ID: 29909467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDS-UPDRS to assess non-motor symptoms after STN DBS for Parkinson's disease.
    Jafari N; Pahwa R; Nazzaro JM; Arnold PM; Lyons KE
    Int J Neurosci; 2016; 126(1):25-9. PubMed ID: 26134878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up.
    Hanna JA; Scullen T; Kahn L; Mathkour M; Gouveia EE; Garces J; Evans LM; Lea G; Houghton DJ; Biro E; Bui CJ; Sulaiman OA; Smith RD
    J Neurosurg; 2018 Sep; 131(3):807-812. PubMed ID: 30265192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of heart rate and blood pressure variability in Parkinson's disease patients after bilateral subthalamic deep brain stimulation].
    Furgała A; Górecka-Mazur A; Fiszer U; Pietraszko W; Thor P; Moskała M; Potasz K; Bukowczan M; Polak J; Krygowska-Wajs A
    Przegl Lek; 2015; 72(5):246-52. PubMed ID: 26817327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-Year Gait and Axial Outcomes of Bilateral STN and GPi Parkinson's Disease Deep Brain Stimulation.
    Mei S; Eisinger RS; Hu W; Tsuboi T; Foote KD; Hass CJ; Okun MS; Chan P; Ramirez-Zamora A
    Front Hum Neurosci; 2020; 14():1. PubMed ID: 32116598
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study.
    Burchiel KJ; Anderson VC; Favre J; Hammerstad JP
    Neurosurgery; 1999 Dec; 45(6):1375-82; discussion 1382-4. PubMed ID: 10598706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessments of axial motor control during deep brain stimulation in parkinsonian patients.
    Robertson LT; Horak FB; Anderson VC; Burchiel KJ; Hammerstad JP
    Neurosurgery; 2001 Mar; 48(3):544-51; discussion 551-2. PubMed ID: 11270544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
    Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term effect of bilateral subthalamic stimulation for advanced Parkinson's disease.
    Chen CC; Lee ST; Wu T; Chen CJ; Chen MC; Lu CS
    Chang Gung Med J; 2003 May; 26(5):344-51. PubMed ID: 12934851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of STN DBS on rigidity in Parkinson's disease.
    Shapiro MB; Vaillancourt DE; Sturman MM; Metman LV; Bakay RA; Corcos DM
    IEEE Trans Neural Syst Rehabil Eng; 2007 Jun; 15(2):173-81. PubMed ID: 17601186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.